Digital and Data Strategy, AbbVie, CA, USA.
Patient Centered Outcomes Research, AbbVie, CA, USA.
Expert Rev Pharmacoecon Outcomes Res. 2024 Jul;24(6):723-730. doi: 10.1080/14737167.2024.2362291. Epub 2024 Jun 11.
Sensor-based digital health technology (DHT) has emerged as a promising means to assess patient functioning within and outside clinical trials. Sensor-based functional outcomes (SBFOs) provide valuable insights that complement other measures of how a patient feels or functions to enhance understanding of the patient experience to inform medical product development.
This perspective paper provides recommendations for defining SBFOs, discusses the core evidence required to support SBFOs to inform decision-making, and considers future directions for the field.
The clinical outcome assessment (COA) development process provides an important starting point for developing patient-centered SBFOs; however, given the infancy of the field, SBFO development may benefit from a hybrid approach to evidence generation by merging exploratory data analysis with patient engagement in measure development. Effective SBFO development requires combining unique expertise in patient engagement, measurement and regulatory science, and digital health and analytics. Challenges specific to SBFO development include identifying concepts of interest, ensuring measurement of meaningful aspects of health, and identifying thresholds for meaningful change. SBFOs are complementary to other COAs and, as part of an integrated evidence strategy, offer great promise in fostering a holistic understanding of patient experience and treatment benefits, particularly in real-world settings.
基于传感器的数字健康技术(DHT)已成为评估患者在临床试验内外功能的一种很有前途的手段。基于传感器的功能结果(SBFO)提供了有价值的见解,补充了其他评估患者感觉或功能的方法,以增强对患者体验的理解,从而为医疗产品开发提供信息。
本观点文章提供了定义 SBFO 的建议,讨论了支持 SBFO 以告知决策所需的核心证据,并考虑了该领域的未来方向。
临床结局评估(COA)的开发过程为开发以患者为中心的 SBFO 提供了一个重要的起点;然而,鉴于该领域尚处于起步阶段,SBFO 的开发可能受益于通过将探索性数据分析与患者参与措施开发相结合来生成证据的混合方法。有效的 SBFO 开发需要结合患者参与、测量和监管科学以及数字健康和分析方面的独特专业知识。SBFO 开发的具体挑战包括确定感兴趣的概念、确保测量健康的有意义方面以及确定有意义变化的阈值。SBFO 是其他 COA 的补充,作为综合证据策略的一部分,在促进对患者体验和治疗益处的全面理解方面具有很大的潜力,特别是在真实环境中。